Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests

References

• Aitken RJ, Chaudhry MQ, Boxall AB, Hull M. 2006. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond) 56:300–306
   PubMed Web of Science ®Google Scholar
• Anders A, James B, Wim DJ, Philippe H, Thomas J, Mats-Olof M, et al. 2009. Risk assessment of products of nanotechnologies. European Commission, Directorate general for health and consumers, Public Health and Risk Assessment. 1–71. Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf
   Google Scholar
• Barlow S, Chesson A, Collins JD, Flynn A, Hardy A, Jany K-D, et al. 2009. The potential risks arising from nanoscience and nanotechnologies on food and feed safety. EFSA J Eur Comm 958:1–39
   Google Scholar
• Brunauer S, Emmett P, Teller E. 1938. Adsorption of gases in multimolecular layers. J Am Chem Soc 60:10
   Google Scholar
• Correia Carreira S, Walker L, Paul K, Saunders M. 2015. The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST. Nanotoxicology 9(S1):66–78
   PubMedGoogle Scholar
• Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, et al. 2007. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050–2055
   PubMed Web of Science ®Google Scholar
• Damoiseaux R, George S, Li M, Pokhrel S, Ji Z, France B, et al. 2011. No time to lose–high throughput screening to assess nanomaterial safety. Nanoscale 3:1345–1360
   PubMed Web of Science ®Google Scholar
• Doak SH, Griffiths SM, Manshian B, Singh N, Williams PM, Brown AP, et al. 2009. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285–293
   PubMed Web of Science ®Google Scholar
• Griffiths SM, Singh N, Jenkins GJ, Williams PM, Orbaek AW, Barron AR, et al. 2011. Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem 83:3778–3785
   PubMed Web of Science ®Google Scholar
• Halamoda Kenzaoui B, Chapuis Bernasconi C, Guney-Ayra S, Juillerat-Jeanneret L. 2012. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem J 441:813–821
   PubMed Web of Science ®Google Scholar
• Han X, Gelein R, Corson N, Wade-Mercer P, Jiang J, Biswas P, et al. 2011. Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 287:99–104
   PubMed Web of Science ®Google Scholar
• Juillerat-Jeanneret L, Aguzzi A, Wiestler OD, Darekar P, Janzer RC. 1992. Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell Dev Biol 28A:537–543
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2009. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370–377
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2012. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 6:1123–1136
   Google Scholar
• Lundqvist M, Sethson I, Jonsson BH. 2004. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. Langmuir 20:10639–10647
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, et al. 2011. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5:7503–7509
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, et al. 2012. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 14:455–464
   PubMed Web of Science ®Google Scholar
• Maynard AD. 2007. Nanotechnology: the next big thing, or much ado about nothing? Ann Occup Hyg 51:1–12
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–235
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005a. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, IRFRSINTSW Group. 2005b. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
   PubMed Web of Science ®Google Scholar
• OECD. 2010. List of manufactured nanomaterials and list of endpoints for phase one of the sponsorship programme for the testing of manufactured nanomaterials: revision. OECD Environ Health Saf Publ Ser Saf Manufactured Nanomaterials 27:1–16
   Google Scholar
• Sanfins E, Dairou J, Hussain S, Busi F, Chaffotte AF, Rodrigues-Lima F, et al. 2011. Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymes. ACS Nano 5:4504–4511
   PubMed Web of Science ®Google Scholar
• Stone V, Johnston H, Schins RP. 2009. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613–626
   PubMed Web of Science ®Google Scholar
• Turci F, Ghibaudi E, Colonna M, Boscolo B, Fenoglio I, Fubini B. 2010. An integrated approach to the study of the interaction between proteins and nanoparticles. Langmuir 26:8336–8346
   PubMed Web of Science ®Google Scholar
• Val S, Hussain S, Boland S, Hamel R, Baeza-Squiban A, Marano F. 2009. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol 21(Suppl 1):115–122
   PubMedGoogle Scholar
• Warheit DB, Sayes CM, Reed KL, Swain KA. 2008. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther 120:35–42
   PubMed Web of Science ®Google Scholar
• Wilhelmi V, Fischer U, van Berlo D, Schulze-Osthoff K, Schins RP, Albrecht C. 2012. Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. Toxicol In Vitro 26:323–334
   PubMed Web of Science ®Google Scholar
• Wörle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261–1268
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu XW, Ma YS, Gao HW. 2010. Interaction of nano-TiO2 with lysozyme: insights into the enzyme toxicity of nanosized particles. Environ Sci Pollut Res Int 17:798–806
   PubMed Web of Science ®Google Scholar